Tirbanibulin is a topical medication, classified as a microtubule inhibitor and Src kinase inhibitor, specifically indicated for the treatment of actinic keratosis on the face or scalp. By disrupting microtubule… Read more






Tirbanibulin is a topical medication, classified as a microtubule inhibitor and Src kinase inhibitor, specifically indicated for the treatment of actinic keratosis on the face or scalp. By disrupting microtubule polymerization and inhibiting Src kinase signaling, the drug effectively induces apoptosis in dysplastic keratinocytes. This category offers high-quality reference standards for Tirbanibulin, including essential impurity profiling markers, related metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for rigorous analytical testing, including method validation, impurity identification, and quantitative quality control during manufacturing and stability studies. Accessing precise reference materials—such as the nitrile and methyl ester derivatives or specific structural analogues—is critical for ensuring the purity and regulatory compliance of topical drug formulations throughout the development lifecycle.